Follow
Lutz Froelich
Lutz Froelich
Professor für Gerontopsychiatrie
Verified email at zi-mannheim.de - Homepage
Title
Cited by
Cited by
Year
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease
D Harold, R Abraham, P Hollingworth, R Sims, A Gerrish, ML Hamshere, ...
Nature genetics 41 (10), 1088-1093, 2009
33132009
TREM2 Variants in Alzheimer's Disease
2 ] Guerreiro, R (Guerreiro, Rita)[ 1, A Wojtas, A (Wojtas, J Bras, J (Bras, ...
NEW ENGLAND JOURNAL OF MEDICINE 368 (2), 117-127, 2013
31012013
Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
BW Kunkle, B Grenier-Boley, R Sims, JC Bis, V Damotte, AC Naj, ...
Nature genetics 51 (3), 414-430, 2019
22432019
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease
P Hollingworth, D Harold, R Sims, A Gerrish, JC Lambert, ...
Nature genetics 43 (5), 429-435, 2011
21832011
Lecanemab in early Alzheimer’s disease
CH Van Dyck, CJ Swanson, P Aisen, RJ Bateman, C Chen, M Gee, ...
New England Journal of Medicine 388 (1), 9-21, 2023
19102023
Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis
WJ Jansen, R Ossenkoppele, DL Knol, BM Tijms, P Scheltens, ...
Jama 313 (19), 1924-1938, 2015
15272015
Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET
K Herholz, E Salmon, D Perani, JC Baron, V Holthoff, L Frölich, ...
Neuroimage 17 (1), 302-316, 2002
10062002
New insights into the genetic etiology of Alzheimer’s disease and related dementias
C Bellenguez, F Küçükali, IE Jansen, L Kleineidam, S Moreno-Grau, ...
Nature genetics 54 (4), 412-436, 2022
9592022
Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease
L Frölich, D Blum-Degen, HG Bernstein, S Engelsberger, J Humrich, ...
Journal of neural transmission 105, 423-438, 1998
9561998
Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis
R Ossenkoppele, WJ Jansen, GD Rabinovici, DL Knol, WM van der Flier, ...
Jama 313 (19), 1939-1950, 2015
6292015
Mild cognitive impairment and deficits in instrumental activities of daily living: a systematic review
K Jekel, M Damian, C Wattmo, L Hausner, R Bullock, PJ Connelly, ...
Alzheimer's research & therapy 7, 1-20, 2015
6212015
On the path to 2025: understanding the Alzheimer’s disease continuum
PS Aisen, J Cummings, CR Jack, JC Morris, R Sperling, L Frölich, ...
Alzheimer's research & therapy 9, 1-10, 2017
4642017
Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease
L Jones, PA Holmans, ML Hamshere, D Harold, V Moskvina, D Ivanov, ...
PloS one 5 (11), e13950, 2010
4512010
Intravenous immunoglobulins containing antibodies against β-amyloid for the treatment of Alzheimer’s disease
RC Dodel, Y Du, C Depboylu, H Hampel, L Frölich, A Haag, U Hemmeter, ...
Journal of Neurology, Neurosurgery & Psychiatry 75 (10), 1472-1474, 2004
4482004
Drug development in Alzheimer’s disease: the path to 2025
J Cummings, PS Aisen, B DuBois, L Frölich, CR Jack, RW Jones, ...
Alzheimer's research & therapy 8, 1-12, 2016
4422016
Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype
L Vermunt, SAM Sikkes, A Van Den Hout, R Handels, I Bos, ...
Alzheimer's & Dementia 15 (7), 888-898, 2019
4342019
Lithium trial in Alzheimer's disease: a randomized, single-blind, placebo-controlled, multicenter 10-week study.
H Hampel, M Ewers, K Burger, P Annas, A Mortberg, A Bogstedt, L Frolich, ...
Journal of Clinical Psychiatry 70 (6), 922, 2009
4212009
Prevalence and prognosis of Alzheimer’s disease at the mild cognitive impairment stage
SJB Vos, F Verhey, L Frölich, J Kornhuber, J Wiltfang, W Maier, O Peters, ...
Brain 138 (5), 1327-1338, 2015
3812015
The future of Alzheimer's disease: the next 10 years
H Hampel, D Prvulovic, S Teipel, F Jessen, C Luckhaus, L Frölich, ...
Progress in neurobiology 95 (4), 718-728, 2011
3342011
Amyloid beta peptide ratio 42/40 but not A beta 42 correlates with phospho-Tau in patients with low- and high-CSF A beta 40 load
J Wiltfang, J (Wiltfang, H Esselmann, H (Esselmann, M Bibl, M (Bibl, ...
JOURNAL OF NEUROCHEMISTRY 101 (4), 1053-1059, 2007
3282007
The system can't perform the operation now. Try again later.
Articles 1–20